Cargando…
A genetically modified Plasmodium berghei parasite as a surrogate for whole-sporozoite vaccination against P. vivax malaria
Two malaria parasite species, Plasmodium falciparum (Pf) and P. vivax (Pv) are responsible for most of the disease burden caused by malaria. Vaccine development against this disease has focused mainly on Pf. Whole-sporozoite (WSp) vaccination, targeting pre-erythrocytic (PE) parasite stages, is a pr...
Autores principales: | Moita, Diana, Maia, Teresa G., Duarte, Miguel, Andrade, Carolina M., Albuquerque, Inês S., Dwivedi, Ankit, Silva, Joana C., González-Céron, Lilia, Janse, Chris J., Mendes, António M., Prudêncio, Miguel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755804/ https://www.ncbi.nlm.nih.gov/pubmed/36526627 http://dx.doi.org/10.1038/s41541-022-00585-8 |
Ejemplares similares
-
A Plasmodium berghei sporozoite-based vaccination platform against human malaria
por: Mendes, António M., et al.
Publicado: (2018) -
Intravital Observation of Plasmodium berghei Sporozoite Infection of the Liver
por: Frevert, Ute, et al.
Publicado: (2005) -
Chimeric Plasmodium falciparum parasites expressing Plasmodium vivax circumsporozoite protein fail to produce salivary gland sporozoites
por: Marin-Mogollon, Catherin, et al.
Publicado: (2018) -
The effect of dosage on the protective efficacy of whole-sporozoite formulations for immunization against malaria
por: Moita, Diana, et al.
Publicado: (2023) -
Five decades of clinical assessment of whole-sporozoite malaria vaccines
por: Nunes-Cabaço, Helena, et al.
Publicado: (2022)